Approaches to predicting the risk of acute cerebrovascular accident in patients with stage 5 chronic kidney disease and bone mineral disorders
https://doi.org/10.36485/1561-6274-2022-26-3-66-71
Abstract
BACKGROUND. Among the causes of death in patients with chronic kidney disease (CKD) on dialysis, cardiovascular complications play a leading role. One of them is acute incidences of cerebral circulation (AICC). The assessment of the impact of mineral and bone disorders on the risk of developing AICC is interesting and on par with the assessment of the impact of traditional risk factors.
THE AIM: to evaluate the effects of bone mineral disorders on the risk of acute cerebrovascular accident in patients with stage 5 D CKD.
PATIENTS AND METHODS. A single-center cohort prospective (three-year) study of 85 patients with stage 5D CKD on program hemodialysis was conducted. In the first stage, we evaluated traditional risk factors (blood pressure, echocardiography parameters) and parameters that reflect bone mineral disorders (parathyroid hormone, blood phosphate, calcium levels, 1.25 (OH) D, fibroblast growth factor-FGF-23, a-klotho of blood). Signs of calcification of the heart valves (CHV) and the aortic wall (CAW) were also recorded. In the second stage, three years later, patients were re-examined with the registration of the endpoint, which was identified as cases of fatal and non-fatal AICC.
RESULTS. Within three years, 10 cases of AICC were registered. Mineral and bone disorders in patients on hemodialysis, such as hyperphosphatemia, CKD and its severity are risk factors for the development of AICC. It is shown that the severity of CCS and pulse pressure levels determined before the dialysis procedure and intradialytic have a positive effect on the risk of AICC. Factors such as FGF-23 and α-Klotho of blood have not demonstrated their effect on the risk of AICC.
About the Authors
A. M. Mambetova
Kabardino-Balkar state University after H. M. Berbekov
Russian Federation
Russian Federation
Aneta M. Mambetova, Prof., Dr. med. Sciences
Department of General Medical Training and Medical Rehabilitation
Faculty of Medicine
360000
st. Chernyshevsky, 173
Kabardino-Balkarian Republic
Nalchik
W. tel.: +78662930080
mob. tel.: +79054391190
Sh. N. Gutarаeva
Republican clinical hospital after Sh. Sh. Ependiev
Russian Federation
Russian Federation
Shamsia N. Gatureva, head of department
Department of Efferent Blood Surgery and Hemodialysis
364047
Khvoynaya st., 5
Chechen Republic
Grozny
I. L. Semyonova
Kabardino-Balkar state University after H. M. Berbekov
Russian Federation
Russian Federation
Irina L. Semenova, Senior Lecturer
Department of General Medical Training and Medical Rehabilitation
Faculty of Medicine
360000
st. Chernyshevsky, 173
Kabardino-Balkarian Republic
Nalchik
References
1. Saran R., Li Y., Robinson B. et al. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis2016; 67 (3): 1–305
2. Tonelli M., Karumanchi S. A., Thadhani R. et al. Epidemiology and mechanisms of uremia-related cardiovascular disease. Circulation 2016; 133 (5): 518–536
3. Ulusoy S., Ozkan G., Guvercin B., Yavuz A. The Relation Between Variability of Intact Parathyroid Hormone, Calcium, and Cardiac Mortality in Hemodialysis Patients. Artificial Organs 2016; 40 (11): 1078–1085
4. Li D., Zhang L., Zuo L. et al. Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing. PLoS ONE 2017; 12 (1): 0168537
5. Милованова Л. Ю. Взаимосвязь фактора роста фибробластов-23 (FGF-23) SKLOTHO, тропонина-I у больных хронической болезнью почек / Л. Ю. Милованова [и др.] // Международный научно-исследовательский журнал. – 2016. – 51 (9-13): 65–68. doi: 10.18454/IRJ.2016.51.074 / Milovanova L. Yu., Kozlovskaya L. V., Milovanova S. Yu. etc. Relation-ship of fibroblast growth factor-23 (FGF-23) KLOTHO, troponin-I in patients with chronic kidney disease. International Research Journal 2016; 51 (9-13): 65–68
6. Drechsler C., Pilz S., Obermayer-Pietsch B. et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J 2010; 31 (18): 2253–2261
7. Gracia-Iguacel C., Gallar P., Qureshi A. R. et al. C. Vitamin D Deficiency in Dialysis Patients: Effect of Dialysis Modality and Implications on Outcome. J of Renal Nutrition 2010; 20 (6): 359–367
8. Eun-Jung K., Bo H. K., Hye Y. J. et al. Serum 25-hydroxyvitamin D as a predictor of hospitalization-free survival in predialysis and dialysis patients with chronic kidney disease: a single-center prospective observational analysis. Kidney Res and Clin Pract 2016; 35 (1): 22–28
9. Liu Y., Lee W. C., Cheng B. C. et al. Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines. Biomed Res Int 2016; 2016: 1523124
10. Zhu J. G., Chen J. B., Cheng B. C. et al. Association between Extreme Values of Markers of Chronic Kidney Disease: Mineral and Bone Disorder and 5-Year Mortality among Prevalent Hemodialysis Patients. Blood Purif 2018; 45 (1-3): 1–7
11. Querido S., Quadros Branco P., Silva Sousa H. et al. Hyper-volemia, hypoalbuminemia and mitral calcification as markers of cardiovascular risk in peritoneal dialysis patients. Rev Port Cardiol 2017; 36 (9): 599–604
12. Wu C. F., Lee Y. F., Lee W. J. et al. Severe aortic arch calcification predicts mortality in patients undergoing peritoneal dialysis. J Formos Med Assoc 2017; 116 (5): 366–372
13. KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int 2017; 7 (1): 1–59
Review
For citations:
Mambetova A.M., Gutarаeva Sh.N., Semyonova I.L. Approaches to predicting the risk of acute cerebrovascular accident in patients with stage 5 chronic kidney disease and bone mineral disorders. Nephrology (Saint-Petersburg). 2022;26(3):66-71. (In Russ.) https://doi.org/10.36485/1561-6274-2022-26-3-66-71
Views:
351
Email this article 